Clinical trial

Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II…

NCT00344370 · Kowa Research Europe, Industry · Completed

Key facts

NCT number NCT00344370
Title Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Official title Double-Blind, Follow-On Study of Pitavastatin (4 mg) Versus Atorvastatin (20 mg and 40 mg), With a Single-Blind Extension of Treatment, in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Lead sponsor Kowa Research Europe, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Type II Diabetes Mellitus, Dyslipidemia
Intervention type Drug
Interventions Pitavastatin, Atorvastatin
Enrollment 214
Start date Aug 1, 2006
Primary completion Apr 1, 2008
Completion Apr 1, 2008
First posted Jun 26, 2006
Last update posted Feb 2, 2010
Countries Denmark, Germany, India, Netherlands, Poland, United Kingdom

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies